Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 265

1.

Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting.

Barcelo C, Aouri M, Courlet P, Guidi M, Braun DL, Günthard HF, Piso RJ, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study .

J Antimicrob Chemother. 2019 May 22. pii: dkz217. doi: 10.1093/jac/dkz217. [Epub ahead of print]

PMID:
31119275
2.

Optimisation of vancomycin exposure in neonates based on the best level of evidence.

Dao K, Guidi M, André P, Giannoni E, Basterrechea S, Zhao W, Fuchs A, Pfister M, Buclin T, Csajka C.

Pharmacol Res. 2019 May 17:104278. doi: 10.1016/j.phrs.2019.104278. [Epub ahead of print]

PMID:
31108184
3.

Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.

Jermini M, Dubois J, Rodondi PY, Zaman K, Buclin T, Csajka C, Orcurto A, E Rothuizen L.

Sci Rep. 2019 Mar 25;9(1):5078. doi: 10.1038/s41598-019-41532-3.

4.

Clindamycin clearance during Cytosorb® hemoadsorption: A case report and pharmacokinetic study.

Poli EC, Simoni C, André P, Buclin T, Longchamp D, Perez MH, Ferry T, Schneider AG.

Int J Artif Organs. 2019 May;42(5):258-262. doi: 10.1177/0391398819831303. Epub 2019 Feb 28.

PMID:
30819024
5.

Imatinib uptake into cells is not mediated by organic cation transporters OCT1, OCT2, or OCT3, but is influenced by extracellular pH.

Blanc Mettral J, Faller N, Cruchon S, Sottas L, Buclin T, Schild L, Choong E, Nahimana A, Decosterd LA.

Drug Metab Lett. 2019 Feb 7. doi: 10.2174/1872312813666190207150207. [Epub ahead of print]

PMID:
30734690
6.

Sub-picomolar quantification of PTH 1-34 in plasma by UHPLC-MS/MS after subcutaneous injection of teriparatide and identification of PTH 1-33, its degradation product.

Eugster PJ, Chtioui H, Herren A, Dunand M, Cappelle D, Bourquin J, Buclin T, Grouzmann E.

J Pharm Biomed Anal. 2019 Mar 20;166:205-212. doi: 10.1016/j.jpba.2019.01.011. Epub 2019 Jan 9.

PMID:
30660035
7.

Intravenous brivaracetam in status epilepticus: Correlation between loading dose, plasma levels and clinical response.

Aicua-Rapun I, André P, Rossetti AO, Decosterd LA, Buclin T, Novy J.

Epilepsy Res. 2019 Jan;149:88-91. doi: 10.1016/j.eplepsyres.2018.12.001. Epub 2018 Dec 3.

PMID:
30530123
8.

Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.

Leuppi-Taegtmeyer AB, Decosterd L, Osthoff M, Mueller NJ, Buclin T, Corti N.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01957-18. doi: 10.1128/AAC.01957-18. Print 2019 Feb.

PMID:
30478168
9.

Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.

Burger R, Guidi M, Calpini V, Lamoth F, Decosterd L, Robatel C, Buclin T, Csajka C, Marchetti O.

J Antimicrob Chemother. 2018 Dec 1;73(12):3413-3422. doi: 10.1093/jac/dky370.

PMID:
30304491
10.

Levetiracetam circulating concentrations and response in status epilepticus.

Perrenoud M, André P, Buclin T, Decosterd LA, Rossetti AO, Novy J.

Epilepsy Behav. 2018 Nov;88:61-65. doi: 10.1016/j.yebeh.2018.08.026. Epub 2018 Sep 18.

PMID:
30241055
11.

Myoglobinuria in two patients with Duchenne muscular dystrophy after treatment with zoledronate: a case-report and call for caution.

Ivanyuk A, García Segarra N, Buclin T, Klein A, Jacquier D, Newman CJ, Bloetzer C.

Neuromuscul Disord. 2018 Oct;28(10):865-867. doi: 10.1016/j.nmd.2018.08.004. Epub 2018 Aug 10.

PMID:
30217487
12.

Comparison against current standards of a DNA aptamer for the label-free quantification of tobramycin in human sera employed for therapeutic drug monitoring.

Tenaglia E, Ferretti A, Decosterd LA, Werner D, Mercier T, Widmer N, Buclin T, Guiducci C.

J Pharm Biomed Anal. 2018 Sep 10;159:341-347. doi: 10.1016/j.jpba.2018.06.061. Epub 2018 Jun 30.

PMID:
30025299
13.

Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study.

Voumard R, Gardiol C, André P, Arensdorff L, Cochet C, Boillat-Blanco N, Decosterd L, Buclin T, de Vallière S.

J Antimicrob Chemother. 2018 Sep 1;73(9):2540-2545. doi: 10.1093/jac/dky224.

PMID:
29982449
14.

Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS).

Winterfeld U, Weber-Schöndorfer C, Schaefer C, von Elm E, Buclin T.

Reprod Toxicol. 2018 Sep;80:68-72. doi: 10.1016/j.reprotox.2018.06.002. Epub 2018 Jun 18.

PMID:
29913205
15.

Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group.

Cristina V, Mahachie J, Mauer M, Buclin T, Van Cutsem E, Roth A, Wagner AD.

JAMA Oncol. 2018 Jul 1;4(7):1003-1006. doi: 10.1001/jamaoncol.2018.1080. No abstract available.

PMID:
29800044
16.

Sensitive quantification of the somatostatin analog AP102 in plasma by ultra-high pressure liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study in rats.

Eugster PJ, Boyle CN, Prod'hom S, Tarasco E, Buclin T, Lutz TA, Harris AG, Grouzmann E.

Drug Test Anal. 2018 Sep;10(9):1448-1457. doi: 10.1002/dta.2400. Epub 2018 May 29.

PMID:
29745052
17.

LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation.

Gallay J, Prod'hom S, Mercier T, Bardinet C, Spaggiari D, Pothin E, Buclin T, Genton B, Decosterd LA.

J Pharm Biomed Anal. 2018 May 30;154:263-277. doi: 10.1016/j.jpba.2018.01.017. Epub 2018 Feb 3.

PMID:
29579633
18.

Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.

Cardoso E, Mercier T, Wagner AD, Homicsko K, Michielin O, Ellefsen-Lavoie K, Cagnon L, Diezi M, Buclin T, Widmer N, Csajka C, Decosterd L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:124-136. doi: 10.1016/j.jchromb.2018.02.008. Epub 2018 Feb 8.

PMID:
29544202
19.

[Use of antiepileptic drugs during breastfeeding : What do we tell the mother?]

Crettenand M, Rossetti AO, Buclin T, Winterfeld U.

Nervenarzt. 2018 Aug;89(8):913-921. doi: 10.1007/s00115-018-0496-2. German.

PMID:
29487964
20.

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.

Conus P, Seidman LJ, Fournier M, Xin L, Cleusix M, Baumann PS, Ferrari C, Cousins A, Alameda L, Gholam-Rezaee M, Golay P, Jenni R, Woo TW, Keshavan MS, Eap CB, Wojcik J, Cuenod M, Buclin T, Gruetter R, Do KQ.

Schizophr Bull. 2018 Feb 15;44(2):317-327. doi: 10.1093/schbul/sbx093.

Supplemental Content

Support Center